Jinxin Fertility Group Limited (HKG: 1951)

Market Cap	7.71B
Revenue (ttm)	3.11B
Net Income (ttm)	334.00M
Shares Out	2.74B
EPS (ttm)	0.12
PE Ratio	22.93
Forward PE	14.52
Dividend	0.06 (2.12%)
Ex-Dividend Date	Jun 27, 2024

Volume	16,688,823
Open	2.900
Previous Close	2.910
Day's Range	2.810 - 2.900
52-Week Range	2.050 - 4.640
Beta	1.41
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, an...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,273
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2023, Jinxin Fertility Group's revenue was 2.79 billion, an increase of 17.95% compared to the previous year's 2.36 billion. Earnings were 344.72 million, an increase of 184.60%.

Financial numbers in CNY